Novel amidinourea derivatives have been synthesised and evaluated for their antiviral activity against Hepatitis C Virus (HCV). A compound with an amidinourea-spermine chemical structure, different from that of standard anti-HCV drugs, showed micromolar activity against HCV and excellent viability. Studies on the mode of action revealed that the new compound may act against HCV through the inhibition
已经合成了新型脒基
脲衍
生物,并评估了它们对丙型肝炎病毒 (HCV) 的抗病毒活性。一种具有脒
脲-
精胺化学结构的化合物,不同于标准的抗 HCV 药物,对 HCV 表现出微摩尔活性和优异的生存能力。对作用方式的研究表明,这种新化合物可能通过抑制 IRES 介导的翻译来对抗 HCV。